Cryotherapy in the management of esophageal dysplasia and malignancy.
Accumulating evidence highlights the promising results seen with endoscopic spray cryotherapy in the treatment of dysplasia associated with Barrett esophagus and esophageal carcinoma. Published studies show that the success of spray cryotherapy to eradicate Barrett high-grade dysplasia is comparable to that for other therapies, with a favourable safety profile and high levels of patient comfort. For patients with untreatable esophageal cancer, spray cryotherapy offers a therapeutic option with the potential for complete eradication in early-stage disease and palliation in advanced cases. The mechanism of tissue injury in cryotherapy is unique, with direct cytotoxic effects and ischemic effects from vascular injury. Increased tumor cell death through induction of apoptosis and immunologic effects require further study.
Halsey
Kevin D
KD
Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, MD 21201-1595, USA.
Greenwald
Bruce D
BD
D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000818:Animals; D001471:Barrett Esophagus / Q000473:pathology / Q000628:therapy*; D000075202:Contraindications; D017679:Cryotherapy / Q000379:methods; D004938:Esophageal Neoplasms / Q000473:pathology / Q000628:therapy*; D004945:Esophagoscopy; D004947:Esophagus / Q000473:pathology*; D006801:Humans